Chemotherapy Clinical Trials
149 recruitingDrug
Phase 272Phase 336Phase 125Not Applicable15Early Phase 11
Showing 1–20 of 149 trials
Recruiting
Phase 2Phase 3
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Gastroesophageal-junction CancerEsophageal AdenocarcinomaMetastatic Gastric Cancer+1 more
Pfizer840 enrolled69 locationsNCT07392892
Recruiting
Phase 2
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Solid TumorsLymphoma
Spectrum Pharmaceuticals, Inc40 enrolled5 locationsNCT04570423
Recruiting
Phase 3
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled285 locationsNCT07222800
Recruiting
Phase 2Phase 3
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Small Cell Lung Cancer ( SCLC )
Pfizer550 enrolled73 locationsNCT07226999
Recruiting
Phase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Estrogen Receptor-Positive Breast CarcinomaHER2-Negative Breast CarcinomaAnatomic Stage II Breast Cancer AJCC v8+2 more
National Cancer Institute (NCI)1,978 enrolled72 locationsNCT07391774
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 1
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Resectable Head and Neck Squamous Cell CarcinomaHuman Papillomavirus-Negative Neck Squamous Cell CarcinomaResectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma+1 more
Mayo Clinic32 enrolled1 locationNCT06997094
Recruiting
Phase 2
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Genentech, Inc.99 enrolled38 locationsNCT04302025
Recruiting
Phase 1
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
BeOne Medicines310 enrolled54 locationsNCT06596473
Recruiting
Phase 1
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Advanced Solid TumorMetastatic Solid Tumor
BeOne Medicines90 enrolled13 locationsNCT06803680
Recruiting
Phase 2
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Lung Non-Small Cell Carcinoma
Alliance for Clinical Trials in Oncology164 enrolled33 locationsNCT07293247
Recruiting
Phase 3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Stage IV Colorectal Cancer AJCC v8Metastatic Colorectal Adenocarcinoma
Alliance for Clinical Trials in Oncology364 enrolled186 locationsNCT05673148
Recruiting
Phase 2
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
Rectal Cancer
Virginia Commonwealth University64 enrolled4 locationsNCT04643366
Recruiting
Phase 3
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
Colorectal, CancerLiver Metastases
Jun Huang24 enrolled1 locationNCT06794086
Recruiting
Phase 2
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Anal CancerHPV-Related CarcinomaSquamous Cell Carcinoma of the Anus
Jennifer Dorth33 enrolled2 locationsNCT07425054
Recruiting
Phase 3
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.320 enrolled1 locationNCT07262567
Recruiting
Phase 2
Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+4 more
Chuangzhen Chen43 enrolled1 locationNCT07339488
Recruiting
Phase 2
Optimal Application Timing of ADC Drugs for Advanced Breast Cancer
Breast Cancer Females
Liaoning Cancer Hospital & Institute120 enrolled1 locationNCT07657130
Recruiting
Phase 1
Hyperpolarized Imaging in Diagnosing Participants With Glioma
Glioma
Susan Chang140 enrolled1 locationNCT03739411
Recruiting
Phase 2
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Lung NeoplasmsSmall Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+3 more
Pfizer40 enrolled12 locationsNCT07476287